Inhibition by mibefradil, a novel calcium channel antagonist, of Ca2+- and volume-activated Cl- channels in macrovascular endothelial cells

British Journal of Pharmacology

Volumn 121, Issue 3, 1997, Pages 547-555

  Nilius, Bernd ^a   Prenen, Jean ^a   Kamouchi, Masahiro ^a   Viana, Felix ^a   Voets, Thomas ^a   Droogmans, Guy ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Ca2+ activated Cl channels; Calcium antagonists; CRAC; Endothelium; Inward rectifier K+ channels; Mibefradil; Patch clamp; Volume activated Cl channels

Indexed keywords

CALCIUM ANTAGONIST; CALCIUM ION; CHLORIDE CHANNEL; CHLORIDE ION; FURA 2; MIBEFRADIL; POTASSIUM CHANNEL; RO 40 597; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL MEMBRANE DEPOLARIZATION; CELL MEMBRANE POTENTIAL; CELL PROLIFERATION; CHLORIDE CURRENT; CONTROLLED STUDY; ENDOTHELIUM CELL; FLUORESCENCE ANALYSIS; HYPERPOLARIZATION; ION CURRENT; MEMBRANE STEADY POTENTIAL; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

ANIMALS; BENZIMIDAZOLES; CALCIUM; CALCIUM CHANNEL BLOCKERS; CATTLE; CELL DIVISION; CELL LINE; CHLORIDE CHANNELS; ENDOTHELIUM, VASCULAR; MEMBRANE POTENTIALS; MIBEFRADIL; POTASSIUM CHANNELS; TETRAHYDRONAPHTHALENES;

EID: 0031011248     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701140     Document Type: Article

References (34)

1. BAKX, A.L., VAN DER WALL, E.E., BRAUN, S., EMANUELSSON, H. BRUSCHKE, A.V. & KOBRIN, I. (1995). Effects of the new calcium antagonist mibefradil (Ro 40-5967) on exercise duration in patients with chronic stable angina pectoris: a multicenter, placebo-controlled study. Ro 40-5967 International Study Group. Am. Heart J., 130, 748-757.
2. BERNINK, P.J., PRAGER, G., SCHELLING, A. & KOBRIN, I. (1996). Antihypertensive properties of the novel calcium antagonist mibefradil (Ro 40-5967). A new generation of calcium antagonists? Mibefradil International Study Group. Hypertension 27, 426-432.
3. 2+ channel antagonist mibefradil (Ro 40-5967). Mol. Pharmacol., 48, 540-549.
4. BILLMAN, G.E. & HAMLIN, R.L. (1996). The effects of mibefradil, a novel calcium channel antagonist on ventricular arrhythmias induced by myocardial ischemia and programmed electrical stimulation. J. Pharmacol. Exp. Ther., 277, 1517-1526.
5. BRAUN, S., VAN DER WALL, E.E., EMANUELSSON, H. & KOBRIN, I. (1996). Effects of a new calcium antagonist, mibefradil (Ro 40-5967), in silent ischemia in patients with stable chronic angina pectoris: a multicenter placebo-controlled study. The Mibefradil International Study Group. J. Am. Coll. Cardiol., 27, 317-322.
6. CHIDA, M., VOELKEL, N.F., ONO, S., TANITA, T. & FUJIMURA, S. (1995). Leukocyte-mediated production of eicosanoids in rat lungs: modulation by a calcium antagonist. Nippon Kyobu Shikkan Gakkai Zasshi, 33, 1198-1203.
7. 3H]-desmethoxyverapamil receptor, is devoid of the negative inotropic effects of verapamil in normal and failing rat hearts. Cardiovasc. Drugs Ther., 4, 731-736.
8. DAUT, J., STANDEN, N.B. & NELSON, M.T. (1994). The role of the membrane potential of endothelial and smooth muscle cells in the regulation of coronary blood flow. J. Cardiovasc. Electrophysiol., 5, 154-181.
9. 2+ inward currents by Ro 40-5967 and verapamil: relation to negative inotropy. Eur. J. Pharmacol., 196, 205-207.
10. GRAY, G.A., CLOZEL, M., CLOZEL, J.P. & BAUMGARTNER, H.R. (1993). Effects of calcium channel blockade on the aortic intima in spontaneously hypertensive rats. Hypertension, 22, 569-576.
11. - currents in human vascular endothelial cells - Role of ionic currents in stimulation of nitric oxide biosynthesis. Circ. Res., 75, 304-314.
12. GROSCHNER, K. & KUKOVETZ, W.R. (1992). Voltage-sensitive chloride channels of large conductance in the membrane of pig aortic endothelial cells. Pflügers Arch. Eur. J. Physiol., 421, 209-217.
13. 2+ antagonist, Ro 40-5967. J. Vasc. Res., 23, 71-77.
14. 2+ entry by histamine and ATP in human aortic endothelial cells. Eur. J. Pharmacol., 266, 213-218.
15. KUNG, C.F., TSCHUDI, M.R., NOLL, G., CLOZEL, J.P. & LUSCHER, T.F. (1995). Differential effects of the calcium antagonist mibefradil in epicardial and intramyocardial coronary arteries. J. Cardiovasc. Pharmacol., 26, 312-318.
16. 2+ channels by Ro 40-5967. Circ. Res., 75, 144-148.
17. NILIUS, B. & CASTEELS, R. (1996). Biology of the vascular wall and its interaction with migratory blood cells. In Comprehensive Human Physiology, ed. Greger, R. & Windhorst, U. pp. 1981 1994. Berlin Heidelberg: Springer Verlag.
18. NILIUS, B. & DROOGMANS, G. (1994). A role for potassium channels in cell proliferation? News in Physiological Sciences, 9, 105-109.
19. - channels. Gen. Pharmacol., 27, 1131-1140.
20. - current by hypotonic volume increase in human endothelial cells. J. Gen. Physiol., 103, 787-805.
21. NILIUS, B., PRENEN, J., SZÜCS, G., WEI, L., TANZI, F., VOETS, T. & DROOGMANS, G. (1997a). Calcium-activated chloride channels in bovine pulmonary artery endothelial cells. J. Physiol. (Cambr.), 498, 381-396.
22. NILIUS, B., VIANA, F. & DROOGMANS, G. (1997b). Ion channels in vascular endothelium. Ann. Rev. Physiol., 59, 145-170.
23. 2+ transients in endothelial cells from human umbilical vein. Proc. Natl. Acad. Sci. U.S.A., 91, 2940-2944.
24. OIKE, M., GERICKE, M., DROOGMANS, G. & NILIUS, B. (1994b). Calcium entry activated by store depletion in human umbilical vein endothelial cells. Cell Calcium, 16, 367-376.
25. ROUX, S, BUHLER, M. & CLOZEL, J.P. (1996). Mechanism of the antiischemic effect of mibefradil, a selective T calcium channel blocker in dogs: comparison with amlodipine. J. Cardiovasc. Pharmacol., 27, 132-139.
26. SCHMITT, R., CLOZEL, J.P., IBERG, N. & BUHLER, F.R. (1995). Mibefradil prevents neointima formation after vascular injury in rats. Possible role of the blockade of the T-type voltage-operated calcium channel. Arterioscler. Thromb. Vasc. Biol., 15, 1161-1165.
27. STRANGE, K. & JACKSON, P.S. (1995). Swelling-activated organic osmolyte efflux: A new role for anion channels. Kidney Int., 48, 994-1003.
28. SZÜCS, G., BUYSE, G., EGGERMONT, J., DROOGMANS, G. & NILIUS, B. (1996). Characterisation of volume-activated chloride currents in endothelial cells from bovine pulmonary artery. J. Membr. Biol., 179, 189-197.
29. VENIANT, M., GRAY, G.A., HEUDES, D., MENARD, J. & CLOZEL, J.P. (1995). Structural changes and cyclic GMP content of the aorta after calcium antagonism or angiotensin converting enzyme inhibition in renovascular hypertensive rats. J. Hypertens., 13, 731-737.
30. VOETS, T., DROOGMANS, G. & NILIUS, B. (1996a). Potent block of volume-activated chloride currents in endothelial cells by the uncharged form of quinine and quinidine. Br. J. Pharmacol., 118, 1869-1871.
31. VOETS, T., DROOGMANS, G. & NILIUS, B. (1996b). Ionic currents in non-stimulated endothelial cells from bovine pulmonary artery. J. Physiol. (Cambr.), 497, 95-107.
32. - currents inhibit endothelial cell proliferation. Pflügers Arch. Eur. J. Physiol., 431, 132-134.
33. VOETS, T., WEI, L, DE SMET, P., VAN DRIESSCHE, W., EGGERMONT, J., DROOGMANS, G. & NILIUS, B. (1996c). Down-regulation of volume-activated chloride currents during muscle differentiation. Am. J. Physiol., (in press).
34. --media in human aortic endothelial cells. Jap. J. Physiol., 45, 111-122.